Novartis announced that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company...
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Otezla (apremilast) for the treatment of adult patients with plaque psoriasis who...
OncoBeta GmbH, a medical device company specialized in innovative epidermal radioisotope therapies announced that the company has received ethics approval from the National Health...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO...
Surgical Innovation Associates, Inc. (SIA), a growth-stage medical device company that manufacturers fully-resorbable, biosynthetic implants for the high-growth, multi-billion-dollar markets of plastic, reconstructive, and...
